Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Naoya Fukunaga"'
Autor:
Motoshi Iwao, Ryota Tanaka, Yosuke Suzuki, Takeshi Nakata, Kohei Aoki, Akihiro Fukuda, Naoya Fukunaga, Ryosuke Tatsuta, Keiko Ohno, Hirotaka Shibata, Hiroki Itoh
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-9 (2021)
Abstract Response to antihypertensive drugs in patients with chronic kidney disease (CKD) has great interindividual variability. Adrenomedullin (ADM) is produced abundantly in hypertension, but clearance is very rapid. Mid-regional proADM (MR-proADM)
Externí odkaz:
https://doaj.org/article/23a40a1458d841bbb79e367f4c2dbd8c
Autor:
Noriko Uesugi, Norihiro Furutera, Nahomi Yamaguchi, Misaki Maruo, Takeshi Nakata, Hirotaka Shibata, Kohei Aoki, Akiko Kudo, Akihiro Fukuda, Naoya Fukunaga, Miyuki Kimoto
Publikováno v:
Internal Medicine. 61:865-869
We herein report a 43-year-old woman with Buerger's disease who presented with nephrotic syndrome, renal dysfunction, and mild hypertension. A kidney biopsy revealed focal segmental glomerulosclerosis (FSGS), but there were no findings associated wit
Autor:
Ryota, Takase, Takeshi, Nakata, Kohei, Aoki, Mitsuhiro, Okamoto, Akihiro, Fukuda, Naoya, Fukunaga, Koro, Goto, Takayuki, Masaki, Hirotaka, Shibata
Publikováno v:
Cureus.
Chronic kidney disease (CKD) is known to be a risk factor for falls. In addition, numerous factors such as impaired body balance and loss of muscle mass were reported as risk factors for falls. Patients with CKD often have edema in their lower extrem
Autor:
Naoya Fukunaga, Norihiro Furutera, Yuko Suenaga, Satoshi Hisano, Takeshi Nakata, Jun Okita, Kohei Aoki, Noriko Uesugi, Tomoko Suzuki, Tsutomu Daa, Yuzo Oyama, Akihiro Fukuda, Hirotaka Shibata
Publikováno v:
CEN Case Rep
We report two cases of idiopathic multicentric Castleman disease (iMCD) with nephrotic syndrome (NS) treated with tocilizumab. Case 1 was a 58-year-old man diagnosed with iMCD prior to the onset of NS. Renal biopsy revealed membranous nephropathy, wh
Autor:
Yuji Sato, Akihiro Fukuda, Abhijit S. Naik, Akihiro Minakawa, Tetsu Mizoguchi, Shuji Nakamura, Shouichi Fujimoto, Hirotaka Shibata, Roger C. Wiggins, Masao Kikuchi, Masanao Nagatomo, Naoya Fukunaga
Publikováno v:
Scientific Reports
Scientific Reports, Vol 10, Iss 1, Pp 1-11 (2020)
Scientific Reports, Vol 10, Iss 1, Pp 1-11 (2020)
Earlier detection of progression risk in diabetic nephropathy will allow earlier intervention to reduce progression. The hypothesis that urinary pellet podocyte mRNA is a more sensitive progression risk marker than microalbuminuria was tested. A cros
Autor:
Shunichiro Honda, Hirotaka Shibata, Eri Hashinaga, Koji Goto, Hiroko Higashi, Yukiko Kawahara, Tomoko Nawata, Hideo Narahara, Naoya Fukunaga, Yuko Yamasaki, Akiko Kudo, Miho Suzuki, Ayumi Ogata, Hiroki Uchida, Kaede Ishida, Shunsuke Yamamoto, Takeshi Nakata, Misaki Maruo, Kouhei Aoki, Takaaki Kitano, Koichi Honda, Kae Ando, Kazunari Murakami
Publikováno v:
Nihon Toseki Igakkai Zasshi. 51:539-544
Autor:
Nahomi Yamaguchi, Akihiro Fukuda, Norihiro Furutera, Miyuki Kimoto, Misaki Maruo, Akiko Kudo, Kohei Aoki, Takeshi Nakata, Noriko Uesugi, Naoya Fukunaga, Hirotaka Shibata
Publikováno v:
Internal Medicine; 2022, Vol. 61 Issue 6, p865-869, 5p
Autor:
Akira Fukui, Naohiko Takahashi, Kohei Aoki, Takayuki Masaki, Yasushi Teshima, Naoya Fukunaga, Yuki Ikebe-Ebata, Tetsuji Shinohara, Shotaro Saito, Hidekazu Kondo
Publikováno v:
Journal of Cardiovascular Electrophysiology. 28:702-710
Hyperleptinemia and Atrial FibrillationBackground Obesity including metabolic syndrome is an independent risk factor of atrial fibrillation (AF). Although hyperleptinemia is usually a characteristic of obese subjects, the relationship with atrial fib
Autor:
Hiroki Itoh, Kohei Aoki, Akihiro Fukuda, Hirotaka Shibata, Nagato Kuriyama, Teruhide Koyama, Fumihiko Katagiri, Yuhki Sato, Naoya Fukunaga, Motoshi Iwao, Etsuko Ozaki, Yosuke Suzuki, Keiko Ohno, Hiromitsu Mimata, Fuminori Sato, Takeshi Nakata, Ryota Tanaka
Publikováno v:
Journal of pharmaceutical and biomedical analysis. 183
Mid-regional pro-adrenomedullin (MR-proADM) is suggested to be a prognostic indicator for various diseases. Plasma MR-proADM concentration is commonly measured using immunoassays based on its immunochemical characteristics. However, some immunologica
Autor:
Hirotaka Shibata, Naoya Fukunaga, Kouhei Aoki, Akihiro Fukuda, Matsuyama Kazuhiro, Kyoko Ojiro, Takeshi Nakata, Youichi Tatsukawa
Publikováno v:
Nephrology Dialysis Transplantation. 34